Infectious Pulmonary Diseases - 08/08/22
Résumé |
Pneumonia is a lower respiratory tract infection caused by the inability to clear pathogens from the lower airway and alveoli. Cytokines and local inflammatory markers are released, causing further damage to the lungs through the accumulation of white blood cells and fluid congestion, leading to pus in the parenchyma. The Infectious Diseases Society of America defines pneumonia as the presence of new lung infiltrate with other clinical evidence supporting infection, including new fever, purulent sputum, leukocytosis, and decline in oxygenation. Importantly, lower respiratory infections remain the most deadly communicable disease. Pneumonia is subdivided into three categories: (1) community acquired, (2) hospital acquired, and (3) ventilator associated. Therapy for each differs based on the severity of the disease and the presence of risk factors for methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa.
Le texte complet de cet article est disponible en PDF.Keywords : Community-acquired pneumonia, Hospital-acquired pneumonia, Ventilator-associated pneumonia, Antimicrobial stewardship, Allergies, Cross-sensitivity, Procalcitonin, MRSA nasal screening
Plan
No commercial or financial conflicts of interest or any funding sources to disclose. |
|
Statement of authorship – both authors contributed equally to this article. |
Vol 40 - N° 3
P. 503-518 - août 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?